Importantly, we demonstrated that the LRRK2 N551K R1398H variant associated with reduced risk for PD and Crohn’s disease leads to a reduction in Rab10 phosphorylation in both cellular models as well as in human subjects, suggesting that this variant may reduce disease risk through its effect on LRRK2’s kinase activity. Here, RAB10 is linked to Crohn disease.